# Steven Le Gouill

Source: https://onco.cc/people/steven-le-gouill/  
OnCo record `steven-le-gouill` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Steven Le Gouill is a lymphoma specialist who leads the Institut Curie hospitals.

## Summary

Steven Le Gouill is Director of the Institut Curie Hospital Group in Paris and a haematologist. His specialisms are lymphoma, mantle cell lymphoma and hospital leadership. He is a lymphoma trialist known for mantle cell lymphoma studies with the LYSA group. His papers include the long-term follow-up of rituximab maintenance in young patients with mantle cell lymphoma in the LYMA trial, the final results of a phase II study of acalabrutinib monotherapy in relapsed or refractory mantle cell lymphoma, and a Blood comparison of obinutuzumab and rituximab for transplant-eligible patients with mantle cell lymphoma. His publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Institut Curie Hospital Group; haematologist
- Specialisms: Lymphoma; Mantle cell lymphoma; Hospital leadership

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Le%20Gouill%20S%5BAuthor%5D%20mantle%20cell%20lymphoma

## Connected records

- cancers: [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/)
- institutions: [Institut Curie](https://onco.cc/institutions/institut-curie/)
- journals: [Haematologica](https://onco.cc/journals/haematologica/)
- companies: [LYSA (The Lymphoma Study Association)](https://onco.cc/companies/lysa/)

---
JSON: https://onco.cc/api/v1/entities/steven-le-gouill.json